PACIRA PHARMACEUTICALS
Pacira Pharmaceuticals Inc. operates as a pharmaceutical company which engages in the development and manufacturing of injectable pharmaceutical products. Pacira Pharmaceuticals Inc. was formerly known as DepoTech Corp. was formerly as SkyePharma Inc. and changed its name to Pacira Pharmaceuticals Inc. in June, 2007. The company was founded in 1989 and is based in San Diego, California. Pacira Pharmaceuticals Inc. operates as a subsidiary of Pacira, Inc.
PACIRA PHARMACEUTICALS
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
1989-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.pacira.com
Total Employee:
501+
Status:
Active
Contact:
973-254-3560
Total Funding:
112.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network Google Universal Analytics Apache Global Site Tag
Similar Organizations
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Current Advisors List
Current Employees Featured
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-10-11 | Flexion Therapeutics | Flexion Therapeutics acquired by Pacira Pharmaceuticals | 427.5 M USD |
| 2019-03-05 | MyoScience | MyoScience acquired by Pacira Pharmaceuticals | 220 M USD |
Investors List
Oxford Finance LLC
Oxford Finance LLC investment in Post-IPO Debt - Pacira Pharmaceuticals
Sanderling Ventures
Sanderling Ventures investment in Series A - Pacira Pharmaceuticals
OrbiMed
OrbiMed investment in Series A - Pacira Pharmaceuticals
HBM Healthcare Investments AG
HBM Healthcare Investments AG investment in Series A - Pacira Pharmaceuticals
MPM Capital
MPM Capital investment in Series A - Pacira Pharmaceuticals
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-04-11 | CarthroniX | Pacira Pharmaceuticals investment in Convertible Note - CarthroniX | 2.25 M USD |
| 2022-03-28 | Spine BioPharma | Pacira Pharmaceuticals investment in Series B - Spine BioPharma | 13 M USD |
| 2022-01-07 | Genascence | Pacira Pharmaceuticals investment in Series A - Genascence | 10.5 M USD |
| 2021-12-02 | CODA Biotherapeutics | Pacira Pharmaceuticals investment in Venture Round - CODA Biotherapeutics | 28 M USD |
| 2021-04-20 | Spine BioPharma | Pacira Pharmaceuticals investment in Convertible Note - Spine BioPharma | 3 M USD |
| 2021-02-15 | GeneQuine Biotherapeutics GmbH | Pacira Pharmaceuticals investment in Series A - GeneQuine Biotherapeutics GmbH | 5.4 M EUR |
| 2021-02-15 | GeneQuine Biotherapeutics GmbH | Pacira Pharmaceuticals investment in Debt Financing - GeneQuine Biotherapeutics GmbH | 2.75 M EUR |
| 2020-08-28 | AVALON.AI | Pacira Pharmaceuticals investment in Seed Round - AVALON.AI | 1.5 M USD |
| 2017-10-30 | TELA Bio | Pacira Pharmaceuticals investment in Venture Round - TELA Bio | 25 M USD |
Newest Events participated
Participated in American Association of Nurse Anesthetists (AANA) 2017 Annual Congress
on 2017-09-08 as exhibitor
Official Site Inspections
http://www.pacira.com Semrush global rank: 2.77 M Semrush visits lastest month: 5.85 K
- Host name: 141.193.213.20
- IP address: 141.193.213.20
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Pacira Pharmaceuticals"
A leader in innovative pain management – About Pacira
For over a decade, Pacira has led the way in targeted, non-opioid pain management. Today, we’re building on that legacy with next-generation innovations for chronic, postsurgical and musculoskeletal pain. But we’re more …See details»
Culture – Life at Pacira
Discover Pacira’s dynamic workplace culture, where innovation, collaboration and a passion for improving patient care drive everything we do.See details»
About Pacira | Our Mission
Access medical and scientific information and resources related to Pacira’s portfolio.See details»
Pacira Announces New Five-Year Objectives to Accelerate
Jan 10, 2025 Pacira Announces New Five-Year Objectives to Accelerate Transition into an Innovative Biopharmaceutical Organization Company also reports preliminary unaudited 2024 …See details»
Contact – Pacira
Get in touch with Pacira. Find contact details for general inquiries, medical information, partnerships and investor relations.See details»
Pacira Pharmaceuticals, Inc.
Explore career opportunities at Pacira Pharmaceuticals, a leader in innovative pain management therapies.See details»
Investors | Pacira BioSciences, Inc.
May 27, 2025 The Investor Relations website contains information about Pacira BioSciences, Inc.'s business for stockholders, potential investors, and financial analysts.See details»
Pacira Pharmaceuticals, Inc.
Pacira Pharmaceuticals, Inc.See details»
Our impact – Pacira
Putting our mission into action. See how we’re driving adoption of safer, non-opioid pain management options through education, advocacy and access.See details»
Pacira BioSciences Reports Second Quarter 2025 Financial Results
4 days ago The Investor Relations website contains information about Pacira BioSciences, Inc.'s business for stockholders, potential investors, and financial analysts.See details»
investor.pacira.com
With a best-in-class commercial portfolio that is producing significant cash flow, we believe we are well equipped to extend our leadership in non-opioid pain management and transform Pacira …See details»
Pacira Announces New Five-Year Objectives to Accelerate …
Jan 10, 2025 With a best-in-class commercial portfolio that is producing significant cash flow, we believe we are well equipped to extend our leadership in non-opioid pain management and …See details»
Explore insights – Pacira
Take charge of your recovery with personalized pain care. Learn about pain and explore non-opioid options with our patient resources.See details»
Contact Us | Get in touch with Pacira
Access medical and scientific information and resources related to Pacira’s portfolio.See details»
Pacira BioSciences Reports First Quarter 2025 Financial Results
May 8, 2025 The Investor Relations website contains information about Pacira BioSciences, Inc.'s business for stockholders, potential investors, and financial analysts.See details»
Pacira Biosciences: A Company Profile in Pain Management
Jul 22, 2025 A profile of Pacira Biosciences’ role in non-opioid pain solutions, detailing its core delivery technology and its path through a complex business landscape.See details»
Corporate Governance - Pacira BioSciences, Inc.
The Investor Relations website contains information about Pacira BioSciences, Inc.'s business for stockholders, potential investors, and financial analysts.See details»
Sustainability – Pacira
Innovation requires responsible business practices, environmental stewardship and patient-centered care. Learn more about our sustainability policies.See details»
Pacira BioSciences Announces Strategic Collaboration to …
Jul 22, 2025 The Investor Relations website contains information about Pacira BioSciences, Inc.'s business for stockholders, potential investors, and financial analysts.See details»
Pacira Pharmaceuticals - Crunchbase Company Profile & Funding
Pacira Pharmaceuticals Inc. was formerly known as DepoTech Corp. was formerly as SkyePharma Inc. and changed its name to Pacira Pharmaceuticals Inc. in June, 2007. The …See details»